Women were less than half of the people tested for almost all of these common medicines.
PregnancyCommunity forum

NCT00922480

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

See it on ClinicalTrials.gov ↗

485 people

150 womenmiddle line = equal numbers335 men
Phase
PHASE3
Paid for by
Boryung Pharmaceutical Co., Ltd
Finished
2009-09
Health conditions
Hypertension
Who could join
Anyone
Ages
18 Years – 70 Years
Average age
mean 53.77 years
Age 65+
Not reported
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
Not reported

Women left out

  • No women who could get pregnant

    Most women roughly 15–50 years old were turned away.

    “Female of childbearing potential who does not undergo hysterectomy or is not post-menopausal”
  • No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    “Patients with a history of myocardial infarction, severe coronary artery disease or clinically significant heart failure or valvular defect in last 6 months”
  • No diabetes

    Women with diabetes were turned away.

    “Patients with sever insulin dependent diabetes mellitus or uncontrolled diabetes mellitus(HbA1c\>9%, regimen change of oral hypoglycemic agents within 12weeks, treated insulin before screening)”

Study titles and rules are shown in their original English.